BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 21341264)

  • 1. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.
    Satoh-Takayama N; Lesjean-Pottier S; Sawa S; Vosshenrich CA; Eberl G; Di Santo JP
    Eur J Immunol; 2011 Mar; 41(3):780-6. PubMed ID: 21341264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
    Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
    J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
    Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22 producing NKp46+ innate lymphoid cells can differentiate from hematopoietic precursor cells.
    Kim MS; Kim WS; Piao ZH; Yun S; Lee SH; Lee S; Jeong M; Sun HN; Park YJ; Jung H; Yoon SR; Choi I
    Immunol Lett; 2011 Dec; 141(1):61-7. PubMed ID: 21835206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of NK cells and NK-like cells from the intestinal lamina propria.
    Sanos SL; Diefenbach A
    Methods Mol Biol; 2010; 612():505-17. PubMed ID: 20033661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
    Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
    J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal Lin- c-Kit+ NKp46- CD4- population strongly produces IL-22 upon IL-1β stimulation.
    Lee Y; Kumagai Y; Jang MS; Kim JH; Yang BG; Lee EJ; Kim YM; Akira S; Jang MH
    J Immunol; 2013 May; 190(10):5296-305. PubMed ID: 23589614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.
    Tumanov AV; Koroleva EP; Guo X; Wang Y; Kruglov A; Nedospasov S; Fu YX
    Cell Host Microbe; 2011 Jul; 10(1):44-53. PubMed ID: 21767811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct requirements for T-bet in gut innate lymphoid cells.
    Sciumé G; Hirahara K; Takahashi H; Laurence A; Villarino AV; Singleton KL; Spencer SP; Wilhelm C; Poholek AC; Vahedi G; Kanno Y; Belkaid Y; O'Shea JJ
    J Exp Med; 2012 Dec; 209(13):2331-8. PubMed ID: 23209316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.
    Satoh-Takayama N; Lesjean-Pottier S; Vieira P; Sawa S; Eberl G; Vosshenrich CA; Di Santo JP
    J Exp Med; 2010 Feb; 207(2):273-80. PubMed ID: 20142427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes.
    Schulthess J; Meresse B; Ramiro-Puig E; Montcuquet N; Darche S; Bègue B; Ruemmele F; Combadière C; Di Santo JP; Buzoni-Gatel D; Cerf-Bensussan N
    Immunity; 2012 Jul; 37(1):108-21. PubMed ID: 22705105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.
    Wang Y; Koroleva EP; Kruglov AA; Kuprash DV; Nedospasov SA; Fu YX; Tumanov AV
    Immunity; 2010 Mar; 32(3):403-13. PubMed ID: 20226692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.
    Colonna M
    Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development.
    Lian RH; Chin RK; Nemeth HE; Libby SL; Fu YX; Kumar V
    Eur J Immunol; 2004 Oct; 34(10):2699-707. PubMed ID: 15368286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage relationship analysis of RORgammat+ innate lymphoid cells.
    Sawa S; Cherrier M; Lochner M; Satoh-Takayama N; Fehling HJ; Langa F; Di Santo JP; Eberl G
    Science; 2010 Oct; 330(6004):665-9. PubMed ID: 20929731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runx3 specifies lineage commitment of innate lymphoid cells.
    Ebihara T; Song C; Ryu SH; Plougastel-Douglas B; Yang L; Levanon D; Groner Y; Bern MD; Stappenbeck TS; Colonna M; Egawa T; Yokoyama WM
    Nat Immunol; 2015 Nov; 16(11):1124-33. PubMed ID: 26414766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gata3 drives development of RORγt+ group 3 innate lymphoid cells.
    Serafini N; Klein Wolterink RG; Satoh-Takayama N; Xu W; Vosshenrich CA; Hendriks RW; Di Santo JP
    J Exp Med; 2014 Feb; 211(2):199-208. PubMed ID: 24419270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota.
    Sawa S; Lochner M; Satoh-Takayama N; Dulauroy S; Bérard M; Kleinschek M; Cua D; Di Santo JP; Eberl G
    Nat Immunol; 2011 Apr; 12(4):320-6. PubMed ID: 21336274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
    Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
    J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.